An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through a non-exclusive internal research license. DUBLIN and CHESHIRE, United Kingdom ...

Dr. Petr Chlanda, virologist and research group leader at the Heidelberg Medical Faculty of Heidelberg University, has been awarded more than 720,000 euros in funding from the European Union for his ...

CRISPR gene-editing technology presents a possible solution for feeding a growing population, but incorporating CRISPR into ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing.

From AI to gene therapy, we reached out to industry experts to get their thoughts on the trends that will shape the biotech ...

This diversification will accelerate in the years to come with the integration of AI with CRISPR as it will allow for faster discovery of more efficient cas variants. The market is growing too – ...

"Programs like AIM are essential to not only driving startups’ innovation journey but also reinforcing UC San Diego's role as ...

CRISPR stock decline is influenced by Editas Medicine's struggles, but CRSP remains strong with FDA approval and strategic ...

In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against other biotech stocks with the biggest upside potential. Improving Trends for Biotech ...

Van Andel Institute’s free Public Lecture Series returns Feb. 5. This year’s lineup will cover topics such as brain cells, ...